/HYPR
HYPR Stock - Hyperfine, Inc.
Healthcare|Medical - DevicesNASDAQ
$1.10+6.80%
+$0.07 (+6.80%) • Dec 19
74
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.53
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.77
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+81.8%upside
Target: $2.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HYPR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.09 – $1.11
TARGET (TP)$2.00
STOP LOSS$1.01
RISK/REWARD1:10.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.09
52W High$2.22
52W Low$0.53
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $12.89M | $11.03M | $6.81M | $1.50M | $294,000 |
| Gross Profit | $5.89M | $4.76M | $907,000 | $-1,167,000 | $-477,000 |
| Gross Margin | 45.7% | 43.1% | 13.3% | -78.0% | -162.2% |
| Operating Income | $-43,224,000 | $-48,115,000 | $-73,874,000 | $-64,868,000 | $-23,491,000 |
| Net Income | $-40,720,000 | $-44,238,000 | $-73,164,000 | $-64,833,000 | $-23,357,000 |
| Net Margin | -315.9% | -401.0% | -1073.7% | -4333.8% | -7944.6% |
| EPS | $-0.56 | $-0.62 | $-1.04 | $-0.92 | $-0.93 |
Company Overview
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HYPRBeat Rate
33%
Last 15 quarters
Avg Surprise
-0.9%
EPS vs Estimate
Beats / Misses
5/4
6 met exactly
Latest EPS
$-0.11
Q4 2025
EPS Surprise History
Q1 24
+11.8%
$-0.15vs$-0.17
Q2 24
0.0%
$-0.14vs$-0.14
Q3 24
0.0%
$-0.14vs$-0.14
Q4 24
0.0%
$-0.14vs$-0.14
Q1 25
+12.5%
$-0.14vs$-0.16
Q2 25
0.0%
$-0.12vs$-0.12
Q3 25
0.0%
$-0.12vs$-0.12
Q4 25
-10.0%
$-0.11vs$-0.10
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 16, 2026 | $-0.08 | — | — | — |
Q4 2025 | Nov 13, 2025 | $-0.10 | $-0.11 | -10.0% | ✗ MISS |
Q3 2025 | Aug 13, 2025 | $-0.12 | $-0.12 | 0.0% | = MET |
Q2 2025 | May 13, 2025 | $-0.12 | $-0.12 | 0.0% | = MET |
Q1 2025 | Mar 17, 2025 | $-0.16 | $-0.14 | +12.5% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $-0.14 | $-0.14 | 0.0% | = MET |
Q3 2024 | Aug 8, 2024 | $-0.14 | $-0.14 | 0.0% | = MET |
Q2 2024 | May 13, 2024 | $-0.14 | $-0.14 | 0.0% | = MET |
Q1 2024 | Mar 21, 2024 | $-0.17 | $-0.15 | +11.8% | ✓ BEAT |
Q4 2023 | Nov 9, 2023 | $-0.15 | $-0.15 | 0.0% | = MET |
Q3 2023 | Aug 14, 2023 | $-0.17 | $-0.15 | +11.8% | ✓ BEAT |
Q2 2023 | May 11, 2023 | $-0.16 | $-0.17 | -6.3% | ✗ MISS |
Q1 2023 | Mar 21, 2023 | $-0.25 | $-0.19 | +24.0% | ✓ BEAT |
Q4 2022 | Nov 10, 2022 | $-0.26 | $-0.19 | +26.9% | ✓ BEAT |
Q3 2022 | Aug 10, 2022 | $-0.27 | $-0.33 | -22.2% | ✗ MISS |
Q2 2022 | May 11, 2022 | $-0.21 | $-0.34 | -61.9% | ✗ MISS |
Q1 2022 | Mar 25, 2022 | — | $-2.73 | — | — |
Q1 2022 | Mar 23, 2022 | — | $-2.73 | — | — |
Q3 2021 | Aug 19, 2021 | — | $-0.21 | — | — |
Q2 2021 | May 17, 2021 | — | $-0.11 | — | — |
Latest News
Hyperfine Gets India Approval For Its Swoop System
📈 PositiveBenzinga•Dec 17, 2025, 01:17 PM
Hyperfine Announces FDA Clearance Of Swoop System Software Update With Advanced Diffusion Imaging Capability
📈 PositiveBenzinga•Dec 15, 2025, 01:16 PM
Hyperfine Secures $3.7M Gates Foundation Grant To Advance AI-Powered Portable Brain MRI Access
📈 PositiveBenzinga•Nov 19, 2025, 01:17 PM
Hyperfine Lowers FY2025 Sales Guidance from $14.179M-$15.468M to $13.000M-$14.000M vs $14.255M Est
📉 NegativeBenzinga•Nov 13, 2025, 09:35 PM
Hyperfine Sees Q4 Sales $5.000M-$6.000M vs $5.980M Est
➖ NeutralBenzinga•Nov 13, 2025, 09:35 PM
Hyperfine shares are trading lower after the company reported worse-than-expected Q3 financial results.
📉 NegativeBenzinga•Nov 13, 2025, 09:34 PM
Hyperfine Q3 EPS $(0.14) Misses $(0.10) Estimate, Sales $3.437M Miss $3.460M Estimate
📉 NegativeBenzinga•Nov 13, 2025, 09:07 PM
Hyperfine Announces It Will Expand Its AI-Powered Swoop Portable MRI System Into Neurosurgical Operating Rooms And Will Launch A Study To Generate Clinical Evidence Supporting Swoop Use During Neurosurgical Procedures
📈 PositiveBenzinga•Oct 21, 2025, 12:20 PM
Hyperfine shares are trading lower after the company announced the pricing of its $17.5 million public offering of 14 million shares at a price of $1.25 per share.
📉 NegativeBenzinga•Oct 16, 2025, 12:09 PM
Hyperfine Prices $17.5M Public Offering Of 14M Shares At $1.25/Share
➖ NeutralBenzinga•Oct 16, 2025, 12:09 PM
Hyperfine announces pricing of $17.5 million public offering
➖ NeutralSeeking Alpha•Oct 16, 2025, 12:07 PM
Hyperfine Sees Q3 Sales $3.400M vs $3.507M Est
📉 NegativeBenzinga•Oct 15, 2025, 10:46 PM
Hyperfine shares are trading lower after the company reported preliminary Q3 revenue results below estimates. Also, the company announced a proposed public offering.
📉 NegativeBenzinga•Oct 15, 2025, 08:09 PM
Hyperfine Sees Prelim Q3 Unaudited Revenue $3.4M Vs $3.507M Est.
📉 NegativeBenzinga•Oct 15, 2025, 08:08 PM
Hyperfine Announces Proposed Public Offering; Terms Not Disclosed
➖ NeutralBenzinga•Oct 15, 2025, 08:07 PM
Hyperfine Secures CE and UKCA Approvals For Optive AI, Advancing Image Quality For Portable MRI Across Europe
📈 PositiveBenzinga•Sep 2, 2025, 12:16 PM
Hyperfine Q2 Revenue Jumps 26 Percent
📈 PositiveThe Motley Fool•Aug 14, 2025, 11:29 AM
Hyperfine Posts Higher Margin in Q2
📈 PositiveThe Motley Fool•Aug 13, 2025, 09:41 PM
Frequently Asked Questions about HYPR
What is HYPR's current stock price?
Hyperfine, Inc. (HYPR) is currently trading at $1.10 per share. The stock has moved +6.80% today.
What is the analyst price target for HYPR?
The average analyst price target for HYPR is $2.00, based on 1 analyst.
What sector is Hyperfine, Inc. in?
Hyperfine, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is HYPR's market cap?
Hyperfine, Inc. has a market capitalization of $0.08 billion, making it a small-cap company.
Does HYPR pay dividends?
No, Hyperfine, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCNTB
Connect Biopharma Holdings Limited
$2.27
Mkt Cap: $0.1B
EDAP
Edap Tms S.a.
$2.94
Mkt Cap: $0.1B
FONR
FONAR Corporation
$14.94
Mkt Cap: $0.1B
IMA
ImageneBio Inc
$6.18
Mkt Cap: $0.1B
LUNG
Pulmonx Corporation
$2.60
Mkt Cap: $0.1B
NSPR
InspireMD, Inc.
$1.99
Mkt Cap: $0.1B
QIPT
Quipt Home Medical Corp.
$3.52
Mkt Cap: $0.2B
QNCX
Quince Therapeutics, Inc.
$3.57
Mkt Cap: $0.2B
RCEL
AVITA Medical, Inc.
$3.46
Mkt Cap: $0.1B
VANI
Vivani Medical, Inc.
$1.39
Mkt Cap: $0.1B
Explore stocks similar to HYPR for comparison